Active ingredients | | Date of last message | Type of reason | AM designation |
Olanzapine | Initial report | 18.07.2025 | Production problem | Zyprexa 7.5 mg coated tablets – OP70 (blister pack) |
Olanzapine embonate monohydrate | Initial report | 18.07.2025 | Production problem | ZYPADHERA 405 mg powder and solvent for the preparation of a depot injection suspension – OP(931mg+3ml) |
Olanzapine embonate monohydrate | Change notification | 18.07.2025 | Production problem | ZYPADHERA 300 mg powder and solvent for the preparation of a depot injection suspension – OP(690mg+3ml) |
Levetiracetam | Initial report | 18.07.2025 | Other | Levetiracetam UCB |
Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) | Change notification | 18.07.2025 | Other | Ferrlecit 62.5 mg |
Zoledronic acid monohydrate | Change notification | 17.07.2025 | Production problem | Zoledronic acid Mylan 4 mg/5 ml concentrate for solution for infusion – OP[4x(4x5ml)] |
Zoledronic acid monohydrate | Change notification | 17.07.2025 | Production problem | Zoledronic acid Mylan 4 mg/5 ml concentrate for solution for infusion – OP5ml |
Paliperidone palmitate | Change notification | 17.07.2025 | Other | Paliperidone AL 25 mg depot injection suspension in a pre-filled syringe |
Tacrolimus monohydrate | Change notification | 17.07.2025 | Other | Tacrolimus AL 3 mg hard capsules, delayed release |
Epoetin beta | Initial report | 17.07.2025 | Other | NeoRecormon 4000 IU injection solution in pre-filled syringe – OP6 |
Duloxetine hydrochloride | Change notification | 17.07.2025 | Production problem | Duloxetine PUREN 40 mg gastro-resistant hard capsules |
Carbamazepine | Initial report | 17.07.2025 | Other | Carbadura 400 mg retard |
Tobramycin | Initial report | 17.07.2025 | Production problem | TOBI Podhaler 28 mg hard capsules with powder for inhalation – OP224(4×56) |
Etoposide | Change notification | 16.07.2025 | Production problem | Eto-Gry 20 mg/ml concentrate for solution for infusion |
Amantadine hemisulfate | Change notification | 16.07.2025 | Other | PK-Merz Infusion |
Clopidogrel besylate | Initial report | 16.07.2025 | Other | Clopidogrel Denk 75 mg film-coated tablets |
Amlodipine besylate; perindopril tert-butylamine | Initial report | 16.07.2025 | Other | Perindopril/amlodipine Denk 8 mg/10 mg tablets |
Amlodipine besylate; perindopril tert-butylamine | Initial report | 16.07.2025 | Other | Perindopril/amlodipine Denk 4 mg/10 mg tablets |
Amlodipine besylate; perindopril tert-butylamine | Initial report | 16.07.2025 | Other | Perindopril/amlodipine Denk 4 mg/5 mg tablets |
Methylphenidate hydrochloride | Change notification | 16.07.2025 | Other | Methylphenidate AL 18 mg prolonged-release tablets |
Methylphenidate hydrochloride | Change notification | 16.07.2025 | Other | Methylphenidate AL 27 mg prolonged-release tablets |
| Initial report | 16.07.2025 | Production problem | Teceos |
Methylphenidate hydrochloride | Change notification | 15.07.2025 | Other | METHYLPHENI TAD 20 mg tablets |
Methylphenidate hydrochloride | Change notification | 15.07.2025 | Other | METHYLPHENI TAD 5 mg tablets |
Methylphenidate hydrochloride | Change notification | 15.07.2025 | Other | METHYLPHENI TAD 10 mg tablets |
Semaglutide | Change notification | 15.07.2025 | Other | Ozempic 1 mg injection solution in a pre-filled pen – OP(3x3ml) |
Rifampicin | Initial report | 15.07.2025 | Production problem | EREMFAT 450 mg |
Methyldopa (Ph.Eur.) | Initial report | 15.07.2025 | Other | Dopegyt tablets |
Aprepitant | Change notification | 15.07.2025 | Production problem | Aprepitant beta 125 mg and 80 mg hard capsules |
Atomoxetine hydrochloride | Change notification | 15.07.2025 | Production problem | Atomoxetine beta 80 mg hard capsules |
Olanzapine embonate monohydrate | Change notification | 15.07.2025 | Production problem | ZYPADHERA 210 mg powder and solvent for the preparation of a depot injection suspension – OP(483mg+3ml) |
Cinacalcet hydrochloride | Change notification | 15.07.2025 | Other | Cinacalcet Mylan 60 mg film-coated tablets – OP(28×1) |
Trandolapril; verapamil hydrochloride | Change notification | 15.07.2025 | Other | Tarka 180 mg/ 2 mg modified-release tablets |
Quetiapine fumarate (Ph.Eur.) | Change notification | 15.07.2025 | Other | Seroquel Prolong 50 mg prolonged-release tablets |
Quetiapine fumarate (Ph.Eur.) | Change notification | 15.07.2025 | Other | Seroquel Prolong 300 mg prolonged-release tablets |
Norepinephrine hydrochloride/noradrenaline hydrochloride | Change notification | 14.07.2025 | Production problem | Arterenol 1 ml |
Epinephrine hydrochloride | Change notification | 14.07.2025 | Production problem | Suprarenin ampoules |
Sodium iodide ((123)I) | Initial report | 14.07.2025 | Other | Sodium iodide (I 123) injection DRN 5375 |
Iobenguan ((123)I) | Initial report | 14.07.2025 | Other | MIBG (I123) injection DRN 5379 |
Quetiapine fumarate (Ph.Eur.) | Initial report | 14.07.2025 | Production problem | Quetiapine Accord 300 mg prolonged-release tablets |
Quetiapine fumarate (Ph.Eur.) | Initial report | 14.07.2025 | Production problem | Quetiapine Accord 50 mg prolonged-release tablets |
Midodrine hydrochloride | Change notification | 14.07.2025 | Other | Gutron tablets |
Insulin lispro | Initial report | 14.07.2025 | Other | Humalog Mix25 KwikPen 100 E/ml injection suspension – OP (5x3ml) |
Carbamazepine | Initial report | 14.07.2025 | Other | Carbamazepine-ratiopharm 400 mg prolonged-release tablets |
Carbamazepine | Initial report | 14.07.2025 | Other | Carbamazepine-ratiopharm 200 mg prolonged-release tablets |
Flucloxacillin sodium 1 H<2>O | Change notification | 14.07.2025 | Production problem | Staphylex 250 mg capsules |
Sodium (methylprednisolone-21-succinate) | Change notification | 14.07.2025 | Other | Urbason solubile forte 1000 mg |